The DOI matches its Crossref record.
Tyrphostins I: synthesis and biological activity of protein tyrosine kinase inhibitors
Open accessAbstract
A novel class of low molecular weight protein tyrosine kinase inhibitors is described. These compounds constitute a systematic series of molecules with a progressive increase in affinity toward the substrate site of the EGF receptor kinase domain. These competitive inhibitors also effectively block the EGF-dependent autophosphorylation of the receptor. The potent EGF receptor kinase blockers examined were found to competitively inhibit the homologous insulin receptor kinase at 10(2)-10(3) higher inhibitor concentrations in spite of the significant homology between these protein tyrosine kinases. These results demonstrate the ability to synthesize selective tyrosine kinase inhibitors. The most potent EGF receptor kinase inhibitors also inhibit the EGF-dependent proliferation of A431/clone 15 cells with little or no effect on EGF independent cell growth. These results demonstrate the potential use of protein tyrosine kinase inhibitors as selective antiproliferative agents for proliferative diseases caused by the hyperactivity of protein tyrosine kinases. We have suggested the name "tyrphostins" for this class of antiproliferative compounds which act as protein tyrosine kinase blockers.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
ERBB receptors and cancer: the complexity of targeted inhibitors
Hynes, N. E., & Lane, H. A. (2005) · Nature Reviews Cancer · doi:10.1038/nrc1609 · Cited by 3,313
Tyrosine Kinase Inhibition: An Approach to Drug Development
Levitzki, A., & Gazit, A. (1995) · Science · doi:10.1126/science.7892601 · Cited by 1,635
Self-citationFDA-approved small-molecule kinase inhibitors
Wu, P., Nielsen, T. E., & Clausen, M. H. (2015) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2015.04.005 · Cited by 1,013
Margolis, B., Rhee, S. G., Felder, S., Mervic, M., Lyall, R., Levitzki, A., Ullrich, A., Zilberstein, A., & Schlessinger, J. (1989) · Cell · doi:10.1016/0092-8674(89)90047-0 · Cited by 753
Self-citationTyrosine kinase – Role and significance in Cancer
Paul, M. K., & Mukhopadhyay, A. K. (2004) · International Journal of Medical Sciences · doi:10.7150/ijms.1.101 · Cited by 624
Defective T cell receptor signaling in mice lacking the thymic isoform of p59fyn
Appleby, M. W., Gross, J. A., Cooke, M. P., Levin, S. D., Qian, X., & Perlmutter, R. M. (1992) · Cell · doi:10.1016/0092-8674(92)90309-z · Cited by 505
Peterson, G., & Barnes, S. (1993) · The Prostate · doi:10.1002/pros.2990220408 · Cited by 412
Prevention of Lipopolysaccharide-Induced Lethal Toxicity by Tyrosine Kinase Inhibitors
Novogrodsky, A., Vanichkin, A., Patya, M., Gazit, A., Osherov, N., & Levitzki, A. (1994) · Science · doi:10.1126/science.8191285 · Cited by 336
Self-citationCharacterization of Tyrosine Phosphorylation of Paxillin in Vitro by Focal Adhesion Kinase
Bellis, S. L., Miller, J. T., & Turner, C. E. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.29.17437 · Cited by 333
Chemical Inhibitors of Protein Kinases
Bridges, A. J. (2001) · Chemical Reviews · doi:10.1021/cr000250y · Cited by 320
Kaupp, G., Reza Naimi-Jamal, M., & Schmeyers, J. (2003) · Tetrahedron · doi:10.1016/s0040-4020(03)00554-4 · Cited by 312
The effect of tyrosine-specific protein phosphorylation on the assembly of adherens-type junctions.
Volberg, T., Zick, Y., Dror, R., Sabanay, I., Gilon, C., Levitzki, A., & Geiger, B. (1992) · The EMBO Journal · doi:10.1002/j.1460-2075.1992.tb05225.x · Cited by 310
Self-citationProbing the Probes: Fitness Factors For Small Molecule Tools
Workman, P., & Collins, I. (2010) · Chemistry & Biology · doi:10.1016/j.chembiol.2010.05.013 · Cited by 299
Klemke, R. L., Yebra, M., Bayna, E. M., & Cheresh, D. A. (1994) · The Journal of cell biology · doi:10.1083/jcb.127.3.859 · Cited by 270
Rioux, B., Peyrot, C., Mention, M. M., Brunissen, F., & Allais, F. (2020) · Antioxidants · doi:10.3390/antiox9040331 · Cited by 44
Metadata
- Authors
- Gazit, A., Yaish, P., Gilon, C., & Levitzki, A.
- Venue
- Journal of Medicinal Chemistry
- Publisher
- American Chemical Society (ACS)
- Published
- 1989-10
- Volume
- 32
- Issue
- 10
- Pages
- 2344-2352
- ISSN
- 0022-2623 (ISSN-L)
- 1520-4804
- OpenAlex
- W1966112698
- Cited by
- 600
- References
- 0
- FWCI
- 7.69
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.